New trials to address the anemia of lower-risk MDS [MDS Professional Report]
Mar 27, 2024
27:58
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
Drs Nikolaos Papadantonakis of Emory, Atlanta, US, and Moshe Mittelman, Tel-Aviv, Israel, discuss trials presented in American Society of Hematology (ASH) 2023 meeting. They provide some data on luspatercept, imetelstat, roxodustat and Ker-050.
כל תכני עושים היסטוריה